Biosimilars Cut Cancer Drug Costs by Nearly $4,000 a Month for Insurers, UCLA Study Shows
A UCLA-led analysis of more than 14,000 patient-drug pairs published in JAMA Oncology found that exclusive biosimilar use was associated ...
A UCLA-led analysis of more than 14,000 patient-drug pairs published in JAMA Oncology found that exclusive biosimilar use was associated ...
A new editorial in BMC Plastic and Reconstructive Surgery argues that AI tools show promise in aesthetic assessment and flap ...
A new Science Policy Forum argues that longevity products already fall under existing FDA regulations and that the real obstacle ...
Researchers at MUSC Hollings Cancer Center warn that smart vaping devices rewarding users with cryptocurrency and game-like incentives could deepen ...
A new review maps how artificial intelligence is transforming oncology drug discovery, clinical decision-making, and regulatory science from molecule design ...
A new perspective outlines the sensing, actuation, algorithmic, regulatory and human factors that must converge before autonomous closed-loop opioid overdose ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine